ArticleBone marrow transplantation2025

Letermovir reduces cytomegalovirus in HLA-matched and mismatched allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide.

Jena Schmitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.